(1S,2R)-(+)-Norephedrine

Modify Date: 2024-01-04 07:20:23

(1S,2R)-(+)-Norephedrine Structure
(1S,2R)-(+)-Norephedrine structure
Common Name (1S,2R)-(+)-Norephedrine
CAS Number 37577-28-9 Molecular Weight 187.667
Density 1.071g/cm3 Boiling Point 288.1ºC at 760mmHg
Molecular Formula C9H13NO Melting Point 51-54ºC
MSDS USA Flash Point 235.4 °F
Symbol GHS07
GHS07
Signal Word Warning

 Names

Name (1S,2R)-(+)-Norephedrine
Synonym More Synonyms

 Chemical & Physical Properties

Density 1.071g/cm3
Boiling Point 288.1ºC at 760mmHg
Melting Point 51-54ºC
Molecular Formula C9H13NO
Molecular Weight 187.667
Exact Mass 187.076385
PSA 46.25000
LogP 1.76750

 Safety Information

Symbol GHS07
GHS07
Signal Word Warning
Hazard Statements H302-H315-H319-H335
Precautionary Statements P261-P305 + P351 + P338
Personal Protective Equipment dust mask type N95 (US);Eyeshields;Gloves
Hazard Codes Xn: Harmful;
Risk Phrases R22;R36/37/38
Safety Phrases S26
RIDADR NONH for all modes of transport
WGK Germany 3
HS Code 2922199090
Flash Point(F) 235.4 °F
Flash Point(C) 113 °C

 Synthetic Route

 Customs

HS Code 2922199090
Summary 2922199090. other amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0%

 Articles28

More Articles
The Psychostimulant Khat (Catha edulis) Inhibits CYP2D6 Enzyme Activity in Humans.

J. Clin. Psychopharmacol. 35 , 694-9, (2015)

The use of khat (Catha edulis) while on medication may alter treatment outcome. In particular, the influence of khat on the metabolic activities of drug-metabolizing enzymes is not known. We performed...

Solvent-free melting techniques for the preparation of lipid-based solid oral formulations.

Pharm. Res. 32(5) , 1519-45, (2015)

Lipid excipients are applied for numerous purposes such as taste masking, controlled release, improvement of swallowability and moisture protection. Several melting techniques have evolved in the last...

The Expected Net Present Value of Developing Weight Management Drugs in the Context of Drug Safety Litigation.

Pharmacoeconomics 33 , 749-63, (2015)

Following withdrawals, failures, and significant litigation settlements, drug product launches in the anti-obesity category slowed despite a large and growing unmet need. Litigation concerns, a more r...

 Synonyms

EINECS 238-900-2
dl-phenylpropanolamine
d-NOREPHEDRINE BASE
(1R,2S)-2-Amino-1-phenyl-1-propanol hydrochloride (1:1)
PHENYLPROPANOLAMINEBASE
d-Phenylpropanolamine
dl-NOREPHEDRINE BASE
MFCD00064411
Benzenemethanol, α-[(1S)-1-aminoethyl]-, (αR)-, hydrochloride (1:1)
dl-propadrine